#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal adenocarcinoma stage III Warm autoimmune haemolytic anaemia Neoplasm ABO haemolytic disease of newborn Haemophilia B without inhibitors Henoch-Schonlein purpura Myelin oligodendrocyte glycoprotein antibody-associated disease Autoimmune myositis Immune-mediated myositis Breast cancer Friedreich's ataxia Cushing's syndrome Uveitis Hodgkin's disease refractory Deafness More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Trials in Disease Fabry’s disease – Treatment Inclusion body myositis Myxofibrosarcoma – Life with Disease MELAS syndrome – Basic Information Familial haemophagocytic lymphohistiocytosis – Trials in Disease Mantle cell lymphoma – Life with Disease Shprintzen-Goldberg syndrome – Trials in Disease Aicardi-Goutieres syndrome Pleural mesothelioma malignant – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Epcoritamab ZINC GLUCONATE Dantrolene Sodium Carisbamate Ly3871801 BENZYLPENICILLIN PROCAINE Autologous Chondrocytes Vafidemstat Digitoxin Stro-002 Abc-23B-116 Pariglasgene Brecaparvovec TALADEGIB COBALAMIN Repagermanium Colchicine Gd2Il18Cart Sodium Butyrate Namodenoson Iron Sucrose More therapies…

    Learn about Your Condition

    Optic ischaemic neuropathy Biliary tract operation Friedreich's ataxia Thermal burn Device related infection Paedophilia Papilloma viral infection Bladder cancer stage III Malformation venous Lupus nephritis Kearns-Sayre syndrome Hydrocephalus Langerhans cell sarcoma Incisional hernia Meningioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Reseau De Sante Mutualiste

Reseau De Sante Mutualiste

158 Rue Leon Blum, Villeurbanne, 69100, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Chemotherapy for Patients with Resected Pancreatic Cancer Using FOLFIRINOX and Drug Combination

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Gemcitabine
    • Irinotecan
    France

  • Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Czechia Denmark France Germany Greece +8

  • Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    • Essential thrombocythaemia
    • Myeloproliferative neoplasm
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Apixaban
    • Rivaroxaban
    France

  • Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • Amikacin Sulfate
    • Amoxicillin Sodium
    France

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Budesonide
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Austria Bulgaria Czechia Denmark Finland France +10

  • Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    France

  • Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small intestine adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Irinotecan Hydrochloride Trihydrate
    France Italy

  • Study on FOLFOX Chemotherapy for Treating Advanced Colon Cancer in Patients Aged 70 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France

  • Study Comparing FOLFIRINOX and Cisplatin-Etoposide for Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    Investigated Drugs:
    • Cisplatin
    • Etoposide
    • Fluorouracil
    France
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!